Clinical Trials Logo

Filter by:
NCT ID: NCT06448533 Completed - Clinical trials for Lower Urinary Tract Symptoms,Prostatic Hyperplasia

The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study

Start date: September 10, 2022
Phase:
Study type: Observational

This study was a retrospective cohort study clinical trial designed to assess the predictive ability of the prostate morphometric parameter, Prostate Spherical Volume Ratio, in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia; and to compare the predictive ability of other anatomical parameters of the prostate (prostatic urethral length, intravesical prostatic protrusion, presumed circle area ratio, and prostate volume) in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia

NCT ID: NCT06447857 Completed - Atrial Fibrillation Clinical Trials

Extracellular Volume Associated With New-Onset Atrial Fibrillation

Start date: January 1, 2020
Phase:
Study type: Observational

Left ventricular fibrosis is strongly associated with atrial fibrillation (AF). However, the relationship between LV fibrosis and new-onset AF (NOAF) after ST-segment elevation myocardial infarction (STEMI) is currently unknown. This study was to investigate the relationship between different regions of ECV and NOAF during the acute phase of STEMI. ECV in integral (integral ECV), non-myocardial infarction region (NMI-ECV) and myocardial infarction region (MI-ECV) was obtained by CMR.

NCT ID: NCT06446219 Completed - Crohn Disease Clinical Trials

Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease

Start date: January 1, 2020
Phase:
Study type: Observational

This study focuses on Upadacitinib, a new oral and small-molecular medication that inhibits specific enzymes involved in inflammation. The goal is to determine efficacy and safety of Upadacitinib for Crohn's Disease patients in China compared with Vedolizumab, which is used to inhibit recruitment of inflammatory cells. Crohn's Disease significantly affects individuals' quality of life and imposes a high burden on society and healthcare systems. Current treatments don't work for everyone, and some patients may need surgery. Upadacitinib has shown promise in other countries for treating Crohn's Disease and related conditions, and has been approved by the US FDA for such use. The investigators' retrospective and multicenter study looks back at patient records from multiple hospitals to analyze the outcomes of those who have received Upadacitinib and Vedolizumab. Investigators aim to enroll patients treated between January 2020 and March 2024, who received follow-up for more than 12 weeks. For patients, families, and healthcare providers, this research could provide a potential new treatment option for Crohn's Disease. Better efficacy and safety of Upadacitinib than Vedolizumab could lead to better management of the disease, possibly reducing the need for surgery and improving the quality of life. The ultimate goal is to provide more personalized and effective treatment strategies for Crohn's Disease patients in China.

NCT ID: NCT06446180 Completed - Oral Mucositis Clinical Trials

Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Start date: January 31, 2024
Phase: N/A
Study type: Interventional

Radiation-induced oral mucositis (RIOM) is the most common oral complication of cancer patients receiving radiotherapy and/or chemotherapy, leading to poor quality of life. the investigators previous studies that have reported the use of single SSK12 probiotics in RIOM. However, SSK12 probiotics alone may lack stability, free radical scavenging activity and oral local targeting.Here, the investigators designed a new oral probiotic K12@Lip@GSH that SSK12 is encapsulated in liposomes(Lip) to enhance its stability and free radical scavenging ability, and glutathione (GSH) transporter-mediated oral targeting agent based on the over-expression of GSH transporters at the RIOM. The investigators have complete evaluated the treatment outcome of SSK12@Lip@GSH on RIOM mice. The investigators designed a single-center, single-arm prospective clinical study to evaluate the efficacy and safety of SsK12@Lip@GSH in the treatment of radioactive oral mucositis in patients with head and neck malignancies

NCT ID: NCT06443957 Completed - Clinical trials for Postoperative Delirium

The Preventive Effect of Different Doses of Intranasal Insulin on Postoperative Delirium

Start date: July 29, 2023
Phase: N/A
Study type: Interventional

Postoperative delirium is one of the common complications in the older aldults after surgery, which can lead to longer hospita stay,memory loss and reduced quality of life. There is currently no specific treatment. Therefore, it is important to prevent the occurrence of postoperative delirium. This study investigated the effect of intranasal insulin administration on the prevention of postoperative delirium and compared different doses of insulin to find a safe and acceptable method for preventing delirium.

NCT ID: NCT06442735 Completed - Clinical trials for Complication of Delivery

Clinical Application of Intrapartum Ultrasound

IPUS
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Intrapartum ultrasound monitoring is to be compared with conventional labor monitoring to clarify the accuracy of this technology, and then provide a basis for later related research.

NCT ID: NCT06441799 Completed - Skin Wrinkles Clinical Trials

Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles

YM-1
Start date: April 17, 2023
Phase: N/A
Study type: Interventional

This is a multicenter trial with randomized control and evaluator blind method, which meets the screening criteria total of 224 subjects were enrolled and randomly divided into control group and experiment according to 1:1 ratio Group), the subjects in the control group used medical ultrasonic coupler, and the subjects in the test group used test instruments Combined with medical ultrasonic coupler, use 5 days per week according to the prescribed use method (duration:Use the whole face for 10 minutes, use twice a day, a total of 20 minutes), continuous use 12Week. The changes of relevant clinical indicators and laboratory instrument measurements were evaluated. Objective : To evaluate the efficacy of radiofRF in reducing skin wrinkles and treating loose skin after 12 weeks of use of the test product Effectiveness and safety of relaxation and firming of skin tissue. The subjects were adults aged 18 years and above, regardless of gender, and had obvious wrinkles on the skin around the face and eyes (according to the selection Standard confirmation).

NCT ID: NCT06441409 Completed - Clinical trials for Nonalcoholic Fatty Liver Disease

Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease

MASLD
Start date: October 18, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if serum ferritin levels has correlated with metabolic dysfunction associated steatotic liver disease(MASLD). It will also learn about the effect of lifestyle intervention on serum ferritin levels and MASLD. The main questions it aims to answer are: Does serum ferritin levels predict the occurence and development of MASLD? Does liver iron overload has correlated with liver fat deposition? Does serum ferritin levels and MASLD got some degree of remission after weight lose with lifestyle intervention? Researchers will compare the liver fatty, liver iron depositon and serum ferritin levels after lifestyle intervention using self pre-and post-control . Participants will: Receive the lifestyle intervention in outpatient. Visit the clinic once after 6 months for checkups and tests. Keep a diary of their diet.

NCT ID: NCT06440161 Completed - Acute Kidney Injury Clinical Trials

Association of Intraoperative Haemodynamic and Postoperative Complications in Type A Aortic Dissection Surgery

Start date: October 1, 2023
Phase:
Study type: Observational

Background To determine whether venous congestion is an important predictor of postoperative kidney injury and other adverse events after type A aortic dissection (TAAD). Methods Authors collected data of adults who underwent surgery for TAAD between January 2016 and July 2023. Primary exposures were venous congestion defined by central venous pressure (CVP) and mean arterial pressure (MAP). The primary outcomes were acute kidney injury (AKI) and acute injury disease (AKD). The secondary outcomes encompassed death and stroke. Restricted cubic spline regression model was used to adjust for confounding factors and multiple comparisons.

NCT ID: NCT06439459 Completed - Skin Regeneration Clinical Trials

Skin Dermal Regeneration After Stromal Vascular Fraction Transplantation

SDR-SVF
Start date: February 15, 2023
Phase: N/A
Study type: Interventional

This study is a prospective, exploratory investigation aimed at exploring the efficacy of stromal vascular fraction (SVF) transplantation in treating exhaustion of dermal regenerative capacity during skin expansion. The dermal thickness, texture, and perfusion before and after SVF transplantation would be recorded and analyzed by a series of quantitative devices including laser 3D scanner, Doppler ultrasound, VISIA skin analyzer, CK skin analyzer, and indocyanine green angiography.